Biotechnology company Infinitopes has raised $35.1 million in a seed financing round to accelerate the development of a precision cancer vaccine. The latest finance round was co-led by Octopus Ventures and new investor Amplify Bio, with further participation from new investor Macmillan Cancer Support and existing investors Cancer Research Horizons and Manta Ray Ventures. “I’m honoured to […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!